Updates for 2020
FDLI remains committed to providing high-quality educational programs while keeping our members and event attendees safe during the current pandemic. With this in mind, we are excited to announce that the 2020 Legal and Practical Issues in the Evolving World of Cannabis Regulation Conference will be a completely virtual event. Please know we are actively exploring options to ensure an engaging and enjoyable experience with ample opportunities to connect with your peers. Be sure to check the conference website regularly for additional announcements and updates.
Why Attend?
What’s the Buzz? Cannabis-derived products are at a dynamic legal and regulatory crossroads at both the state and federal level. While cannabis-derived substances above 0.3% THC are still illegal at the federal level, states are continuing to legalize cannabis for medical and/or recreational use; many states even designated cannabis businesses as “essential” during the initial phases of the COVID-19 pandemic. Simultaneously, CBD products, many with unsubstantiated drug claims or containing toxic substances, continue to proliferate despite scant FDA oversight. This conference will examine the present reality of this unique industry from both a legal and practical perspective and guide attendees on how to navigate this constantly changing legal environment. Industry experts will untangle the issues related to CBD, cannabis, and other cannabinoids, various regulated product areas (e.g., topicals, supplements, edibles, drugs), and state vs. federal regulation.
Conference Highlights:
- The current federal regulatory landscape for CBD-derived products
- CBD safety, product quality, labeling, and marketing considerations
- CBD litigation and enforcement trends
- Updates on the Agriculture Improvement Act of 2018 implementation
- Cannabis state legalization developments
- Cannabis research initiatives and regulatory updates
Call For Proposals
FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this summer. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in September.
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Sponsors
Sponsorship opportunities are available. Please let us know if you would like more information.
Planning Committee
Committee Members
Libby Baney, Faegre Drinker
Linda D. Bentley, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Kelly Fair, Canopy Growth Corporation
William A. Garvin, Buchanan Ingersoll & Rooney PC
Steven N. Levine, Husch Blackwell LLP
Brian J. Malkin, McDermott Will & Emery
Keith Matthews, Wiley LLP
Daniel McGee, Solari Hemp
Douglas MacKay, CV Sciences
Debby Miran,DMiran Consulting
Heike Newman, Senior Regulatory Manager, University of Colorado
Megan L. Olsen, Council for Responsible Nutrition
Christopher Van Gundy, Sheppard Mullin Richter & Hampton LLP
Deborah Walter, Greenwich Biosciences
Daniel Wang, Pinney Associates, Inc.
Jessica Anne Wasserman, WassermanRowe